---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-026300"
form_type: "8-K/A"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2021-10-26T23:59:59+00:00"
generated_at: "2026-06-28T18:02:53.619745+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics corrects typo in prior 8-K; confirms 320K share and warrant sale for $400K

## Summary
- Amendment corrects share count to 320,000 shares of common stock and warrants for 320,000 shares.
- Gross proceeds from sale to accredited investors total $400,000, consummated October 20, 2021.
- Warrants allow purchase of 320,000 shares of common stock; terms not specified in filing.

## SEC filing metadata
- accession: 0001493152-21-026300
- form_type: 8-K/A
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2021-10-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315221026300/0001493152-21-026300-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315221026300/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-026300
- JSON: https://secwatch.observer/filing/0001493152-21-026300.json
- Plain text: https://secwatch.observer/filing/0001493152-21-026300.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.